Insights

Expansive Market Reach Daye's recent success in helping over 75,000 women and AFAB individuals with menstrual health demonstrates strong market demand and a growing customer base that values innovative, tech-enabled health solutions.

Innovative Product Portfolio With the launch of the second-generation at-home detection tampon and plans to develop solutions for under-served conditions like endometriosis and PCOS, there are opportunities to expand product offerings and increase customer engagement.

Strong Revenue Potential The company's revenue range of 100 million to 250 million USD, supported by recent funding of 12 million USD, indicates solid financial health and scalability prospects suitable for strategic partnerships or market expansion.

Tech-Driven Approach Utilizing advanced technologies such as Google Cloud, Tableau, and Open Graph positions Daye as a modern, data-driven company, making it attractive for collaborations involving digital health innovation and data analytics.

Growing Market Trends Targeting female health and wellness, particularly in reproductive and gynecological areas, aligns with expanding global market trends emphasizing personalized health monitoring and women’s health empowerment.

Daye Tech Stack

Daye uses 8 technology products and services including Tableau, Open Graph, Prismic, and more. Explore Daye's tech stack below.

  • Tableau
    Business Intelligence
  • Open Graph
    Content Management System
  • Prismic
    Content Management System
  • Google Cloud
    Infrastructure As A Service
  • Loadable-Components
    Javascript Libraries
  • Trustpilot
    Online Review Management
  • Recurly
    Payment Processing
  • Google Tag Manager
    Tag Management

Media & News

Daye's Email Address Formats

Daye uses at least 1 format(s):
Daye Email FormatsExamplePercentage
First@yourdaye.comJohn@yourdaye.com
41%
First.Last@yourdaye.comJohn.Doe@yourdaye.com
9%
First@yourdaye.comJohn@yourdaye.com
41%
First.Last@yourdaye.comJohn.Doe@yourdaye.com
9%

Frequently Asked Questions

Where is Daye's headquarters located?

Minus sign iconPlus sign icon
Daye's main headquarters is located at London, England se16 4dg United Kingdom. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Daye's stock symbol?

Minus sign iconPlus sign icon
Daye is a publicly traded company; the company's stock symbol is NAVODAYENT.BO.

What is Daye's official website and social media links?

Minus sign iconPlus sign icon
Daye's official website is yourdaye.com and has social profiles on LinkedInCrunchbase.

What is Daye's NAICS code?

Minus sign iconPlus sign icon
Daye's NAICS code is 92312 - Administration of Public Health Programs.

How many employees does Daye have currently?

Minus sign iconPlus sign icon
As of February 2026, Daye has approximately 102 employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Operations Officer: A. P.Chief Technology Officer: E. C.Head Of Data & Analytics: K. T.. Explore Daye's employee directory with LeadIQ.

What industry does Daye belong to?

Minus sign iconPlus sign icon
Daye operates in the Public Health industry.

What technology does Daye use?

Minus sign iconPlus sign icon
Daye's tech stack includes TableauOpen GraphPrismicGoogle CloudLoadable-ComponentsTrustpilotRecurlyGoogle Tag Manager.

What is Daye's email format?

Minus sign iconPlus sign icon
Daye's email format typically follows the pattern of First@yourdaye.com. Find more Daye email formats with LeadIQ.

How much funding has Daye raised to date?

Minus sign iconPlus sign icon
As of February 2026, Daye has raised $12M in funding. The last funding round occurred on Oct 26, 2022 for $12M.

When was Daye founded?

Minus sign iconPlus sign icon
Daye was founded in 2017.

Daye

Public HealthEngland, United Kingdom51-200 Employees

Daye is a female-founded gynae health start-up on a mission to close the gender health gap for good. We started out with the invention of the world’s first pain-relieving tampon, designed to support the 90% of women who experience menstrual cramps.

After helping over 75,000 women & AFAB individuals kick period pain to the curb, we launched our second generation tampon to facilitate the at-home detection of vaginal infections, STIs and HPV. 

Next, we want to develop solutions for under-served gynae health conditions like endometriosis, PCOS and menopause. Within the next five years, we will build an ecosystem where every woman can understand, monitor, and improve her health from her smartphone.

Section iconCompany Overview

Headquarters
London, England se16 4dg United Kingdom
Stock Symbol
NAVODAYENT.BO
NAICS Code
92312 - Administration of Public Health Programs
Founded
2017
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $12M

    Daye has raised a total of $12M of funding over 3 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $12M.

  • $100M$250M

    Daye's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $12M

    Daye has raised a total of $12M of funding over 3 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $12M.

  • $100M$250M

    Daye's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.